{"id":"NCT01895855","sponsor":"Bavarian Nordic","briefTitle":"Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera","officialTitle":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial of a Single Dose Live Oral Cholera Vaccine, PXVX0200 CVD 103-HgR, in Preventing Cholera Following Challenge With Vibrio Cholerae 10 Days or 3 Months After Vaccination","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09","primaryCompletion":"2014-11","completion":"2014-11","firstPosted":"2013-07-11","resultsPosted":"2021-04-01","lastUpdate":"2023-06-28"},"enrollment":197,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Cholera"],"interventions":[{"type":"BIOLOGICAL","name":"PXVX0200","otherNames":[]},{"type":"BIOLOGICAL","name":"placebo","otherNames":[]}],"arms":[{"label":"PXVX0200","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to determine if PXVX0200 is safe and effective in preventing cholera infection","primaryOutcome":{"measure":"% of Participants With Moderate to Severe Diarrhea","timeFrame":"Ten days after vaccination","effectByArm":[{"arm":"PXVX0200","deltaMin":5.7,"sd":null},{"arm":"Placebo","deltaMin":59.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":13,"exclusionCount":9},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":["27001804","29655627","28566334","31743334","29624592"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":95},"commonTop":["Fatigue","Upper Respiratory tract infection","Flatulence","Rhinorrhoea","Musculoskeletal pain"]}}